Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium

References

• Ahmed IS, Aboul-Einien MH 2007. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofuvin. Eur. J. Pharm. Sci. 32, 58–68.
   PubMed Web of Science ®Google Scholar
• Amidon GL Lennernas H Shah VP, Crison JR 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413–420.
   Google Scholar
• Ballantyne CM Herd JA Ferlic LL Dunn JK Farmer JA Jones PH Schein JR, GottoJr. AM 1999. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation 99, 736–743.
   PubMed Web of Science ®Google Scholar
• Bhargava S, Agrawal GP 2008. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Curr. Drug Deliv. 5, 1–6.
   PubMedGoogle Scholar
• Corveleyn S, Remon JP 1998a. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int. J. Pharm. 166, 65–74.
   Web of Science ®Google Scholar
• Corveleyn S, Remon JP 1998b. Bioavailability of hydrochlorothiazide: conventional versus freeze-dried tablets. Int. J. Pharm. 173, 149–155.
   Web of Science ®Google Scholar
• Corveleyn S, Remon JP 1999. Stability of freeze-dried tablets at different relative humidities. Drug Dev. Ind. Pharm. 25, 1005–1013.
   PubMed Web of Science ®Google Scholar
• Elversson J, Millqvist-Fureby A 2006. In situ coating-An approach for particle modification and encapsulation of proteins during spray-drying. Int. J. Pharm. 323, 52–63.
   PubMed Web of Science ®Google Scholar
• Floyd AG 1999. Top ten considerations in the development of parenteral emulsions. Pharm. Sci. Technol. To. 2, 134–143.
   Google Scholar
• Gordon DJ Probstfield JL Garrison RJ Neaton JD, Castelli WP Knoke JD JacobsJr. DR Bangdiwala S, Tyroler HA 1989. High-density lipoprowith lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8–15.
   PubMed Web of Science ®Google Scholar
• Grove M Müllertz A, Nielsen JL, Pedersen GP 2006. Bioavailability of seocalcitol II: Development and characterization of self-microemulsifying drug delivery system (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur. J. Pharm. Sci. 28, 233–242.
   PubMed Web of Science ®Google Scholar
• Heinzelmann K, Franke K 1999. Using freezing and drying techniques of emulsions for the microencapsulation of fish oil to improve oxidation stability. Colloids Surf. B 12, 223–229.
   Web of Science ®Google Scholar
• Itoh K, Matsui S 2002. Improvement of physicochemical properties of N-4472 Part II: characterization of N-4472 microemulsion and the enhanced oral absorption. Int. J. Pharm. 246, 75–83.
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 1, 85–96.
   PubMed Web of Science ®Google Scholar
• Kearney AS, Crawford LF, Mehta SC, Radebaugh GW 1993. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydrocyacid forms of the HMG-CoA reductase inhibitor. CI-981. Pharm. Res. 10, 1461–1465.
   PubMed Web of Science ®Google Scholar
• Molina C, Cadorniga R 1995. Physical stability of lyophilized and sterilized emulsions. (S.T.P.) Pharma Pratiques 5, 63–72.
   Google Scholar
• Nakamoto Y, Hashida M, Muranishi S, Sezaki H 1975. Studies on pharmaceutical modification of anticancer agents. Enhanced delivery of bleomycin into lymph by emulsions and drying emulsions. Chem. Pharm. Bull. 23, 3125–3131.
   PubMed Web of Science ®Google Scholar
• Okonogi S, Oguchi T, Yonemochi E, Puttipipatkhachorn S, Yamamoto K 1997. Improved dissolution of ofloxacin via solid dispersion, Int. J. Pharm. 156, 175–180.
   Web of Science ®Google Scholar
• Pedersen GP, Fäldt P, Bergenståhl B, Kristensen HG 1998a. Solid state characterisation of a dry emulsion: a potential drug delivery system. Int. J. Pharm. 171, 257–270.
   Google Scholar
• Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ 1998b. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97, 1453–1460.
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman SA, Williams RD, Bakalova MV, Charman WN 1996. Evaluation of emulsifiable glasses for the oral administration of cyclosporin in beagle dogs. Int. J. Pharm. 141, 227–237.
   Google Scholar
• Shen H, Zhong M 2006. Preparation and evaluation of self-microemulsifying drug delivery system (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 58, 1183–1191.
   PubMed Web of Science ®Google Scholar
• Shively ML 1993a. Characterization of oil-in-water emulsions prepared from solid-state emulsions: effect of matrix and oil phase. Pharm. Res. 10, 1153–1156.
   PubMed Web of Science ®Google Scholar
• Shively ML 1993b. Droplet size distribution within oil-inwater emulsions prepared from solid state dispersions. J. Colloid Interface Sci. 155, 66–69.
   Web of Science ®Google Scholar
• Shively ML, Dec SF 1994. Solid-state emulsions: evaluation by 1H and 13C solid-state nuclear magnetic resonance. Pharm. Res. 11, 1301–1305.
   PubMed Web of Science ®Google Scholar
• Shively ML, Thompson DC 1995. Oral bioavailability of vancomycin solid-state emulsions. Int. J. Pharm. 117, 119–122.
   Web of Science ®Google Scholar
• Takeuchi H, Sasaki H, Niwa T, Hino T, Kawashima Y, Uesugi K, Ozawa H 1992a. Design of redispersible dry emulsion as an advanced dosage form of oily drug (vitamin E nicotinate) by spray-drying technique. Drug Dev. Ind. Pharm. 18, 919–937.
   Web of Science ®Google Scholar
• Takeuchi H, Sasaki H, Niwa T, Hino T, Kawashima Y, Uesugi K, Ozawa H 1992b. Improvement of photostability of ubidecarenone in the formulation of a novel powdered dosage form termed redispersible dry emulsion. Int. J. Pharm. 86, 25–33.
   Web of Science ®Google Scholar
• Tarr BD, Yalkowsky SH 1989. Enhancement intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm. Res. 6, 40–43.
   PubMed Web of Science ®Google Scholar
• Welin-Berger K, Bergenståhl B 2000. Inhibition of Ostwald ripening in local anesthetic emulsions by using hydrophobic excipients in the disperse phase. Int. J. Pharm. 200, 249–260.
   PubMed Web of Science ®Google Scholar
• Witztum, J. L. 1996. Drugs used in the treatment of hyperlipoproteinemias. In: The pharmacological Basis of Therapeutics, 9th ed, eds Ruddon JG, Limbird LE, Molinoff PB, Ruddon RW, 875–897. New York, McGraw-Hill.
   Google Scholar
• Wu CY, Benet LZ 2005. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22, 11–23.
   PubMed Web of Science ®Google Scholar